Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 42 entries
Sorted by: Best Match Show Resources per page
[Multiple sclerosis: pathogenesis and manifestations in children].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Brissaud O, Palin K, Chateil JF, Pedespan JM.
PMID: 11582940
Arch Pediatr. 2001 Sep;8(9):969-78. doi: 10.1016/s0929-693x(01)00564-4.

Multiple sclerosis (MS) is rare in children and occurs exceptionally before ten years. Sex ratio (girl/boy) is around 2.5 to 3, higher than in adults. Brain stem dysfunction and meningeal symptoms are more commonly first manifestations of the disease...

Cite
Brissaud O, Palin K, Chateil JF, et al. Sclérose en plaques: pathogénie et formes de révélation chez l'enfant. [Multiple sclerosis: pathogenesis and manifestations in children]. Arch Pediatr. 2001;8(9):969-78doi: 10.1016/s0929-693x(01)00564-4.
Brissaud, O., Palin, K., Chateil, J. F., & Pedespan, J. M. (2001). Sclérose en plaques: pathogénie et formes de révélation chez l'enfant. [Multiple sclerosis: pathogenesis and manifestations in children]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 8(9), 969-78. https://doi.org/10.1016/s0929-693x(01)00564-4
Brissaud, O, et al. "Sclérose en plaques: pathogénie et formes de révélation chez l'enfant." [Multiple sclerosis: pathogenesis and manifestations in children]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie vol. 8,9 (2001): 969-78. doi: https://doi.org/10.1016/s0929-693x(01)00564-4
Brissaud O, Palin K, Chateil JF, Pedespan JM. Sclérose en plaques: pathogénie et formes de révélation chez l'enfant. [Multiple sclerosis: pathogenesis and manifestations in children]. Arch Pediatr. 2001 Sep;8(9):969-78. doi: 10.1016/s0929-693x(01)00564-4. French. PMID: 11582940.
Copy Download .nbib Format: NLM
Multiple sclerosis. An exercise in hope.

Nursing times

Cornell S.
PMID: 8716191
Nurs Times. 1996 Jun 12-8;92(24):33.

No abstract available.

Cite
Cornell S. Multiple sclerosis. An exercise in hope. Nurs Times. 1996;92(24):33
Cornell, S. (1996). Multiple sclerosis. An exercise in hope. Nursing times, 92(24), 33.
Cornell, S. "Multiple sclerosis. An exercise in hope." Nursing times vol. 92,24 (1996): 33.
Cornell S. Multiple sclerosis. An exercise in hope. Nurs Times. 1996 Jun 12-8;92(24):33. PMID: 8716191.
Copy Download .nbib Format: NLM
[Multiple sclerosis--a new approach to pathophysiology, diagnosis and therapy].

Vojnosanitetski pregled

Dordević D, Raicević R, Marić D, Jovicić A.
PMID: 8629374
Vojnosanit Pregl. 1995 Jul-Aug;52(4):377-87.

No abstract available.

Cite
Dordević D, Raicević R, Marić D, et al. Multipla skleroza--novi pristup patofiziologiji, dijagnostici i terapiji. [Multiple sclerosis--a new approach to pathophysiology, diagnosis and therapy]. Vojnosanit Pregl. 1995;52(4):377-87
Dordević, D., Raicević, R., Marić, D., & Jovicić, A. (1995). Multipla skleroza--novi pristup patofiziologiji, dijagnostici i terapiji. [Multiple sclerosis--a new approach to pathophysiology, diagnosis and therapy]. Vojnosanitetski pregled, 52(4), 377-87.
Dordević, D, et al. "Multipla skleroza--novi pristup patofiziologiji, dijagnostici i terapiji." [Multiple sclerosis--a new approach to pathophysiology, diagnosis and therapy]. Vojnosanitetski pregled vol. 52,4 (1995): 377-87.
Dordević D, Raicević R, Marić D, Jovicić A. Multipla skleroza--novi pristup patofiziologiji, dijagnostici i terapiji. [Multiple sclerosis--a new approach to pathophysiology, diagnosis and therapy]. Vojnosanit Pregl. 1995 Jul-Aug;52(4):377-87. Serbian. PMID: 8629374.
Copy Download .nbib Format: NLM
The mechanisms of lesion genesis in multiple sclerosis?.

Brain : a journal of neurology

Wolinsky JS.
PMID: 10388788
Brain. 1999 Jul;122:1211-2. doi: 10.1093/brain/122.7.1211.

No abstract available.

Cite
Wolinsky JS. The mechanisms of lesion genesis in multiple sclerosis?. Brain. 1999;122:1211-2doi: 10.1093/brain/122.7.1211.
Wolinsky, J. S. (1999). The mechanisms of lesion genesis in multiple sclerosis?. Brain : a journal of neurology, 1221211-2. https://doi.org/10.1093/brain/122.7.1211
Wolinsky, J S. "The mechanisms of lesion genesis in multiple sclerosis?." Brain : a journal of neurology vol. 122 (1999): 1211-2. doi: https://doi.org/10.1093/brain/122.7.1211
Wolinsky JS. The mechanisms of lesion genesis in multiple sclerosis?. Brain. 1999 Jul;122:1211-2. doi: 10.1093/brain/122.7.1211. PMID: 10388788.
Copy Download .nbib Format: NLM
[Multiple sclerosis. Magnetic resonance imaging and spectroscopy].

Presse medicale (Paris, France : 1983)

Cabanis EA, Tourbah A, Iba-Zizen MT, Stievenart JL, Lyon-Caen O.
PMID: 9435839
Presse Med. 1997 Oct 25;26(32):1547-53.

No abstract available.

Cite
Cabanis EA, Tourbah A, Iba-Zizen MT, et al. Sclérose en plaques. Imagerie et spectroscopie par résonance magnétique. [Multiple sclerosis. Magnetic resonance imaging and spectroscopy]. Presse Med. 1997;26(32):1547-53
Cabanis, E. A., Tourbah, A., Iba-Zizen, M. T., Stievenart, J. L., & Lyon-Caen, O. (1997). Sclérose en plaques. Imagerie et spectroscopie par résonance magnétique. [Multiple sclerosis. Magnetic resonance imaging and spectroscopy]. Presse medicale (Paris, France : 1983), 26(32), 1547-53.
Cabanis, E A, et al. "Sclérose en plaques. Imagerie et spectroscopie par résonance magnétique." [Multiple sclerosis. Magnetic resonance imaging and spectroscopy]. Presse medicale (Paris, France : 1983) vol. 26,32 (1997): 1547-53.
Cabanis EA, Tourbah A, Iba-Zizen MT, Stievenart JL, Lyon-Caen O. Sclérose en plaques. Imagerie et spectroscopie par résonance magnétique. [Multiple sclerosis. Magnetic resonance imaging and spectroscopy]. Presse Med. 1997 Oct 25;26(32):1547-53. French. PMID: 9435839.
Copy Download .nbib Format: NLM
Multiple sclerosis.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)

Sutton L.
PMID: 9512592
Nurs Stand. 1998 Jan 7-13;12(16):48-51; quiz 53, 56. doi: 10.7748/ns.12.16.48.s50.

No abstract available.

Cite
Sutton L. Multiple sclerosis. Nurs Stand. 1998;12(16):48-51; quiz 53, 56doi: 10.7748/ns.12.16.48.s50.
Sutton, L. (1998). Multiple sclerosis. Nursing standard (Royal College of Nursing (Great Britain) : 1987), 12(16), 48-51; quiz 53, 56. https://doi.org/10.7748/ns.12.16.48.s50
Sutton, L. "Multiple sclerosis." Nursing standard (Royal College of Nursing (Great Britain) : 1987) vol. 12,16 (1998): 48-51; quiz 53, 56. doi: https://doi.org/10.7748/ns.12.16.48.s50
Sutton L. Multiple sclerosis. Nurs Stand. 1998 Jan 7-13;12(16):48-51; quiz 53, 56. doi: 10.7748/ns.12.16.48.s50. PMID: 9512592.
Copy Download .nbib Format: NLM
Epidemiology of Multiple Sclerosis.

Neurologic clinics

Howard J, Trevick S, Younger DS.
PMID: 27720001
Neurol Clin. 2016 Nov;34(4):919-939. doi: 10.1016/j.ncl.2016.06.016. Epub 2016 Aug 18.

The epidemiology of multiple sclerosis (MS) includes a consideration of genetic and environmental factors. Comparative studies of different populations have revealed prevalence and incidence rates that vary with geography and ethnicity. With a prevalence ranging from 2 per 100,000...

Cite
Howard J, Trevick S, Younger DS. Epidemiology of Multiple Sclerosis. Neurol Clin. 2016;34(4):919-939doi: 10.1016/j.ncl.2016.06.016.
Howard, J., Trevick, S., & Younger, D. S. (2016). Epidemiology of Multiple Sclerosis. Neurologic clinics, 34(4), 919-939. https://doi.org/10.1016/j.ncl.2016.06.016
Howard, Jonathan, et al. "Epidemiology of Multiple Sclerosis." Neurologic clinics vol. 34,4 (2016): 919-939. doi: https://doi.org/10.1016/j.ncl.2016.06.016
Howard J, Trevick S, Younger DS. Epidemiology of Multiple Sclerosis. Neurol Clin. 2016 Nov;34(4):919-939. doi: 10.1016/j.ncl.2016.06.016. Epub 2016 Aug 18. PMID: 27720001.
Copy Download .nbib Format: NLM
Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation.

Behavioural neurology

Messinis L, Papathanasopoulos P, Kosmidis MH, Nasios G, Kambanaros M.
PMID: 29576817
Behav Neurol. 2018 Feb 27;2018:4831647. doi: 10.1155/2018/4831647. eCollection 2018.

No abstract available.

Cite
Messinis L, Papathanasopoulos P, Kosmidis MH, et al. Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation. Behav Neurol. 2018;2018:4831647doi: 10.1155/2018/4831647.
Messinis, L., Papathanasopoulos, P., Kosmidis, M. H., Nasios, G., & Kambanaros, M. (2018). Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation. Behavioural neurology, 20184831647. https://doi.org/10.1155/2018/4831647
Messinis, Lambros, et al. "Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation." Behavioural neurology vol. 2018 (2018): 4831647. doi: https://doi.org/10.1155/2018/4831647
Messinis L, Papathanasopoulos P, Kosmidis MH, Nasios G, Kambanaros M. Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation. Behav Neurol. 2018 Feb 27;2018:4831647. doi: 10.1155/2018/4831647. eCollection 2018. PMID: 29576817; PMCID: PMC5848101.
Copy Download .nbib Format: NLM
Selection of patients for clinical trials.

Neuroepidemiology

Compston A.
PMID: 3627343
Neuroepidemiology. 1987;6(1):34-9. doi: 10.1159/000110098.

Since there is no treatment of proven value in patients with MS it is necessary still to select those patients for inclusion in clinical trials who have most to gain and can demonstrate rapidly the effectiveness or not of...

Cite
Compston A. Selection of patients for clinical trials. Neuroepidemiology. 1987;6(1):34-9doi: 10.1159/000110098.
Compston, A. (1987). Selection of patients for clinical trials. Neuroepidemiology, 6(1), 34-9. https://doi.org/10.1159/000110098
Compston, A. "Selection of patients for clinical trials." Neuroepidemiology vol. 6,1 (1987): 34-9. doi: https://doi.org/10.1159/000110098
Compston A. Selection of patients for clinical trials. Neuroepidemiology. 1987;6(1):34-9. doi: 10.1159/000110098. PMID: 3627343.
Copy Download .nbib Format: NLM
Highlights from the 31st ECTRIMS congress - Barcelona 2015.

Multiple sclerosis (Houndmills, Basingstoke, England)

Sastre-Garriga J, Wiendl H.
PMID: 26684283
Mult Scler. 2016 Jan;22(1):7-10. doi: 10.1177/1352458515620500.

No abstract available.

Cite
Sastre-Garriga J, Wiendl H. Highlights from the 31st ECTRIMS congress - Barcelona 2015. Mult Scler. 2016;22(1):7-10doi: 10.1177/1352458515620500.
Sastre-Garriga, J., & Wiendl, H. (2016). Highlights from the 31st ECTRIMS congress - Barcelona 2015. Multiple sclerosis (Houndmills, Basingstoke, England), 22(1), 7-10. https://doi.org/10.1177/1352458515620500
Sastre-Garriga, Jaume, and Wiendl, Heinz. "Highlights from the 31st ECTRIMS congress - Barcelona 2015." Multiple sclerosis (Houndmills, Basingstoke, England) vol. 22,1 (2016): 7-10. doi: https://doi.org/10.1177/1352458515620500
Sastre-Garriga J, Wiendl H. Highlights from the 31st ECTRIMS congress - Barcelona 2015. Mult Scler. 2016 Jan;22(1):7-10. doi: 10.1177/1352458515620500. PMID: 26684283.
Copy Download .nbib Format: NLM
MS patients must have access to the best treatment options.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)

Mitchell M.
PMID: 24823585
Nurs Stand. 2014 May 20;28(37):35. doi: 10.7748/ns.28.37.35.s40.

No abstract available.

Cite
Mitchell M. MS patients must have access to the best treatment options. Nurs Stand. 2014;28(37):35doi: 10.7748/ns.28.37.35.s40.
Mitchell, M. (2014). MS patients must have access to the best treatment options. Nursing standard (Royal College of Nursing (Great Britain) : 1987), 28(37), 35. https://doi.org/10.7748/ns.28.37.35.s40
Mitchell, Michelle. "MS patients must have access to the best treatment options." Nursing standard (Royal College of Nursing (Great Britain) : 1987) vol. 28,37 (2014): 35. doi: https://doi.org/10.7748/ns.28.37.35.s40
Mitchell M. MS patients must have access to the best treatment options. Nurs Stand. 2014 May 20;28(37):35. doi: 10.7748/ns.28.37.35.s40. PMID: 24823585.
Copy Download .nbib Format: NLM
A review of current and emerging therapeutic strategies in multiple sclerosis.

The American journal of managed care

Tullman MJ.
PMID: 23544717
Am J Manag Care. 2013 Feb;19(2):S21-7.

Multiple sclerosis (MS) is a chronic immune-mediated disease that potentially requires symptomatic and disease-modifying therapies. Numerous symptoms (eg, fatigue, spasticity, depression, bowel and bladder dysfunction, pain, and impaired mobility) are associated with the neurologic damage that results from MS....

Cite
Tullman MJ. A review of current and emerging therapeutic strategies in multiple sclerosis. Am J Manag Care. 2013;19(2):S21-7
Tullman, M. J. (2013). A review of current and emerging therapeutic strategies in multiple sclerosis. The American journal of managed care, 19(2), S21-7.
Tullman, Mark J. "A review of current and emerging therapeutic strategies in multiple sclerosis." The American journal of managed care vol. 19,2 (2013): S21-7.
Tullman MJ. A review of current and emerging therapeutic strategies in multiple sclerosis. Am J Manag Care. 2013 Feb;19(2):S21-7. PMID: 23544717.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 42 entries